K Trademark

Trademark Overview


On Wednesday, January 5, 2022, a trademark application was filed for K with the United States Patent and Trademark Office. The USPTO has given the K trademark a serial number of 97204204. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, January 24, 2025. This trademark is owned by Kymera Therapeutics, Inc.. The K trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and medical preparations for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; Pharmaceutical therapeutics for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases

Research and development of therapeutic drugs for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; Research and development of therapeutic antibodies and pharmaceuticals; Research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services and drug discovery services; Medical research for development of therapeutic modalities for treatment of diseases; Custom design and development of biochemical assays and chemical reagents for use in scientific and biomedical research; Clinical studies, namely, clinical research in the field of oncology, immune oncology, and autoimmune diseases; Preclinical and clinical development of therapeutic products being pharmaceutical preparations and medicines
k

General Information


Serial Number97204204
Word MarkK
Filing DateWednesday, January 5, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, January 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements


Description of MarkThe mark consists of two four-sided polygons above a downward-facing letter "K", where the two polygons form the eyes of an animal's face and the letter "K" forms the nose and mouth of an animal's face.
Goods and ServicesPharmaceutical and medical preparations for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; Pharmaceutical therapeutics for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development of therapeutic drugs for the treatment of cancer, immune inflammatory diseases, and autoimmune diseases; Research and development of therapeutic antibodies and pharmaceuticals; Research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services and drug discovery services; Medical research for development of therapeutic modalities for treatment of diseases; Custom design and development of biochemical assays and chemical reagents for use in scientific and biomedical research; Clinical studies, namely, clinical research in the field of oncology, immune oncology, and autoimmune diseases; Preclinical and clinical development of therapeutic products being pharmaceutical preparations and medicines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKymera Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Party NameKymera Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events


Event DateEvent Description
Saturday, January 8, 2022NEW APPLICATION ENTERED
Tuesday, October 11, 2022NON-FINAL ACTION WRITTEN
Monday, January 10, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 11, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, October 11, 2022ASSIGNED TO EXAMINER
Tuesday, October 11, 2022NON-FINAL ACTION E-MAILED
Tuesday, October 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 21, 2022ASSIGNED TO EXAMINER
Tuesday, April 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 22, 2024SOU EXTENSION 1 FILED
Monday, January 22, 2024SOU EXTENSION 1 GRANTED
Wednesday, January 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 22, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 18, 2024SOU EXTENSION 2 FILED
Thursday, July 18, 2024SOU EXTENSION 2 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 18, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 24, 2025SOU TEAS EXTENSION RECEIVED
Friday, January 24, 2025SOU EXTENSION 3 FILED
Saturday, January 25, 2025SOU EXTENSION 3 GRANTED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED